Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
CRYO CELL INTERNATIONAL INC (CCEL)
|
Add to portfolio |
|
|
|
| Price: |
$11.50
| | Metrics |
| OS: |
8.39
|
M
| |
38
|
% ROE
|
| Market cap: |
$96.5
|
M
| |
1
|
% ROIC
|
|
Net cash:
|
$2.45
|
M
| |
$0.29
|
per share
|
|
EV:
|
$94
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$716.1
|
k
| |
131.3
|
x EV/EBITDA
|
|
EBIT
|
($285.6)
|
k
| |
|
|
| EPS |
$0.19
| |
60.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Nov-30-21 | Nov-30-20 | Nov-30-19 | Nov-30-18 | Nov-30-17 | Nov-30-16 | Nov-30-15 | Nov-30-14 |
| Revenues | 28.9 | 31.1 | 31.8 | 29.2 | 25.4 | 23.1 | 21.1 | 20.1 |
| Revenue growth | -7.3% | -2.1% | 8.9% | 15.1% | 9.8% | 9.7% | 4.8% | 6.0% |
| Cost of goods sold | 9.0 | 9.7 | 10.0 | 8.5 | 6.7 | 5.8 | 5.6 | 5.6 |
| Gross profit | 19.9 | 21.5 | 21.8 | 20.7 | 18.7 | 17.4 | 15.5 | 14.5 |
| Gross margin | 68.9% | 69.0% | 68.5% | 70.8% | 73.5% | 75.0% | 73.3% | 72.0% |
| Selling, general and administrative | 15.9 | 13.8 | 14.9 | 15.6 | 13.5 | 14.7 | 12.4 | 12.3 |
| Research and development | | | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 |
| EBITA | 1.3 | 2.5 | 5.2 | 5.3 | 5.0 | 2.5 | 2.9 | 1.7 |
| EBITA margin | 4.5% | 8.0% | 16.2% | 18.0% | 19.9% | 10.7% | 13.9% | 8.3% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT | 1.2 | 2.4 | 5.1 | 5.2 | 5.0 | 2.4 | 2.9 | 1.6 |
| EBIT margin | 4.2% | 7.8% | 15.9% | 17.8% | 19.7% | 10.5% | 13.8% | 8.2% |
| Pre-tax income | 2.6 | 5.0 | 3.4 | 3.6 | 3.6 | -2.5 | 0.9 | 0.7 |
| Income taxes | 0.5 | 1.4 | 1.1 | 4.5 | 1.3 | -1.2 | -7.2 | 0.1 |
| Tax rate | 20.2% | 28.1% | 32.5% | 123.6% | 36.1% | 46.7% | | 18.2% |
| Net income | 2.1 | 3.6 | 2.3 | -0.9 | 2.3 | -1.3 | 8.1 | 0.6 |
| Net margin | 7.2% | 11.6% | 7.2% | -2.9% | 9.1% | -5.7% | 38.4% | 2.8% |
| |
| Diluted EPS | $0.25 | $0.45 | $0.27 | ($0.11) | $0.30 | ($0.16) | $0.83 | $0.05 |
| Shares outstanding (diluted) | 8.4 | 8.1 | 8.4 | 7.5 | 7.7 | 8.1 | 9.8 | 10.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|